WO2005123731A3
Pyrrolopyridine derivatives and their use as crth2 antagonists
Abstract
There are provided according to the invention compounds of formula (I), in free or salt form, wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO03066047A1 | Cites | World Intellectual Property Organization (WIPO) | Y | International search | 1-10 |
| EP1424325A1 | Cites | European Patent Office (EPO) | Y | International search | 1-10 |
| EP1505061A1 | Cites | European Patent Office (EPO) | PY | International search | 1-10 |
| WO2004007451A1 | Cites | World Intellectual Property Organization (WIPO) | Y | International search | 1-10 |
| WO2005040112A1 | Cites | World Intellectual Property Organization (WIPO) | PA | International search | 1-10 |
| WO2005121141A1 | Cites | World Intellectual Property Organization (WIPO) | E | International search | 1-10 |
64 members in 34 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 0413619 | United Kingdom | A | |
| 0413619 | United Kingdom | A | |
| 0507693 | United Kingdom | A | |
| 0507693 | United Kingdom | A | |
| 04136198 | – | – | – |
| 05076930 | – | – | – |
| GB20040013619 | – | – | – |
| GB20050007693 | – | – | – |
Members64
| Document | Office | Kind | |
|---|---|---|---|
| GB0413619D0 | United Kingdom | D0 | |
| GB0507693D0 | United Kingdom | D0 | |
| AU2005254681A1 | Australia | A1 | |
| CA2569125A1 | Canada | A1 | |
| WO2005123731A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2005123731A3This record | World Intellectual Property Organization (WIPO) | A3 | |
| PE20060301A1 | Peru | A1 | |
| TW200617009A | Taiwan Province of China | A | |
| AR049443A1 | Argentina | A1 | |
| ECSP067077A | Ecuador | A | |
| MXPA06014694A | Mexico | A | |
| NO20070323L | Norway | L | |
| EP1761529A2 | European Patent Office (EPO) | A2 | |
| KR20070032694A | Republic of Korea | A | |
| IL179604D0 | Israel | D0 | |
| MA28666B1 | Morocco | B1 | |
| CN101035786A | China | A | |
| EP1761529B1 | European Patent Office (EPO) | B1 | |
| AT378338T | Austria | T | |
| ATE378338T1 | Austria | T1 | |
| HK1103730A1 | Hong Kong, China | A1 | |
| JP2008502638A | Japan | A | |
| BRPI0512060A | Brazil | A | |
| PT1761529E | Portugal | E | |
| TNSN06410A1 | Tunisia | A1 | |
| HRP20080022T3 | Croatia | T3 | |
| DK1761529T3 | Denmark | T3 | |
| ES2294717T3 | Spain | T3 | |
| PL1761529T3 | Poland | T3 | |
| SI1761529T1 | Slovenia | T1 | |
| US2008114022A1 | United States of America | A1 | |
| RU2007101277A | Russian Federation | A | |
| ZA200609527B | South Africa | B | |
| DE602005003365T2 | Germany | T2 | |
| AU2005254681B2 | Australia | B2 | |
| NZ551439A | New Zealand | A | |
| RU2379309C2 | Russian Federation | C2 | |
| US7666878B2 | United States of America | B2 | |
| RS50552B | Serbia | B | |
| US2010204225A1 | United States of America | A1 | |
| US2010210610A1 | United States of America | A1 | |
| DE602005003365D1 | Germany | D1 | |
| EP1761529B3 | European Patent Office (EPO) | B3 | |
| HRP20080022T4 | Croatia | T4 | |
| TWI352702B | Taiwan Province of China | B | |
| MY144903A | Malaysia | A | |
| PL1761529T6 | Poland | T6 | |
| JP4886680B2 | Japan | B2 | |
| ES2294717T7 | Spain | T7 | |
| CN101035786B | China | B | |
| DE602005003365T3 | Germany | T3 | |
| KR101183330B1 | Republic of Korea | B1 | |
| CA2569125C | Canada | C | |
| US8455645B2 | United States of America | B2 | |
| CY1107851T1 | Cyprus | T1 | |
| US8470848B2 | United States of America | B2 | |
| US2013267518A1 | United States of America | A1 | |
| IL179604A | Israel | A | |
| US8791256B2 | United States of America | B2 | |
| US2014309254A1 | United States of America | A1 | |
| US9169251B2 | United States of America | B2 | |
| NO338319B1 | Norway | B1 | |
| BRPI0512060B1 | Brazil | B1 | |
| BRPI0512060B8 | Brazil | B8 |
31 legal events, as 4 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Wipo information: published in national officeWWP | WWP | WO | |
| Entry into the national phaseENP | ENP | BR | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: grant in national officeWWG | WWG | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: published in national officeWWP | WWP | WO | |
| Wipo information: published in national officeWWP | WWP | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Entry into the national phaseENP | ENP | AU | |
| Wipo information: published in national officeWWP | WWP | WO | |
| Non-entry into the national phaseNENP | NENP | DE | |
| Wipo information: withdrawn in national officeWithdrawnWWW | WWW | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Wipo information: entry into national phaseWWE | WWE | WO | |
| Ep: the epo has been informed by wipo that ep was designated in this application121 | 121 | WO | |
| Designated statesAK | AK | WO | |
| Designated countries for regional patentsAL | AL | WO |
Numbers
- Publication
- 2005/123731
- Publication, DOCDB
- 2005123731
- Publication, EPODOC
- WO2005123731
- Application
- 6493
- Application, DOCDB
- 2005006493
- Application, EPODOC
- WO2005EP06493
Titles2
- English
- PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS
- French
- COMPOSES ORGANIQUES
Classification
- CPC, 11
- C07D471/04
- A61K31/437
- A61P11/00
- A61P11/08
- A61P11/14
- A61P25/00
- A61P29/00
- A61P37/00
- A61P37/08
- A61K31/4738
- A61K45/06
- IPC, 2
- C07D471 04
- A61K31 437
Designated states4
- Regional, 4
- Zimbabwe
- Turkmenistan
- Türkiye
- Togo